(Q74541532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

Hirano T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Oka K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Umezawa Y

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Hirata M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Oh-i T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Koga M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

465-470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

T lymphocyte activation in acute severe asthma

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

7 January 2021

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

The mechanisms of action of cyclosporin A in the treatment of psoriasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Cyclosporin monitoring in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Long-term treatment of psoriasis with cyclosporin A--side-effects, minimal effective dose and cyclosporin blood levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Telepharmacodynamics to predict therapeutic effects of glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Characterization of skin-infiltrating lymphocytes in patients with psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Genomic, Phenotypic, and Functional Analyses of T Cells in Patients with Psoriasis Undergoing Systemic Cyclosporin A Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Interleukin 2 and psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Cyclosporin A Inhibits the Antigen-Presenting Functions of Freshly Isolated Human Langerhans Cells In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990042-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(98)90042-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9585801%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference